Effect of Combination Therapy with a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor on Renal Hypertrophy and Urinary Albumin Excretion in Diabetic Rats
2003

Effect of Combination Therapy on Kidney Health in Diabetic Rats

Sample size: 157 publication Evidence: moderate

Author Information

Author(s): Birgitte Nielsen, Henning Gronbaek, Ruth Osterby, Allan Flyvbjerg

Primary Institution: Aarhus University Hospital

Hypothesis

Does the combination of a calcium channel blocker and an ACE inhibitor reduce kidney damage in diabetic rats?

Conclusion

Nitrendipine effectively reduced urinary albumin excretion in diabetic rats, while enalapril did not, and only the combination of both treatments showed significant benefits after delaying treatment.

Supporting Evidence

  • Nitrendipine reduced urinary albumin excretion to nondiabetic levels.
  • Enalapril did not significantly reduce urinary albumin excretion.
  • Combination therapy showed significant reduction in urinary albumin excretion after 3 months of untreated diabetes.

Takeaway

This study found that a specific medicine can help diabetic rats' kidneys stay healthier, especially when given right after diabetes starts.

Methodology

Diabetes was induced in Wistar rats, which were then treated with nitrendipine, enalapril, both, or placebo for 9 weeks, followed by analysis of urinary albumin excretion and kidney morphology.

Potential Biases

Potential bias due to the exclusion of animals based on strict criteria, which may affect the generalizability of the results.

Limitations

The study may have variability in urinary albumin excretion measurements due to biological variation and the timing of treatment.

Participant Demographics

Adult female Wistar rats, mean body weight of 200 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/15438600390244362

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication